Skip to main content

Silver-linings in COVID-19 – a Fireside Chat with Industry Leaders

Thank you

This live web event has ended. Thank you for attending.


  • Acceleration in technology adoption, contingency planning, and going back to the basics of good data management -- How is COVID-19 shaping the role of Clinical Data Management?
  • Join-in for an interactive conversation and learn how industry leaders are addressing the Clinical Data challenges posed by COVID-19 within their respective organizations, and strategies they are putting in place to not just learn and adopt to COVID-19, but also to build a stronger and more viable Clinical Data Science organizations of the future.

 Sanjay Bhardwaj,
Executive Director, and Head of Clinical Data Management, Allergan/AbbVie and Vice-Chair of the Board at SCDM


  • Demetris Zambas, Head of Data Monitoring and Management, Pfizer

    Demetris is currently VP and Global Head of Data Monitoring and Management at Pfizer. Demetris started his career as a Laboratory Scientist in 1991 and transitioned into the Clinical Development space where he held roles of increasing responsibilities in Trial Management and Monitoring and led the implementation of the company’s first Clinical Trial Management system. In 2000, Demetris was a member and eventually the leader of the team which executed the industry’s first Tech- Transfer of a web based EDC system. He eventually led the Data Management and Standards organization and continued on to Merck & Co. following the merger in 2009. Subsequently Demetris was Vice President of Data Management at Novartis AG from 2014 to 2017. Since 2017 Demetris leads Pfizer’s Data Management and Risk Based Monitoring line functions in a new transformation; developing and transitioning into an internal operating model across multiple geographic sites in support of Pfizer’s portfolio. He also leads the Data and Automation work stream as part of Pfizer’s Development-wide transformation effort. He currently serves on multiple Boards, including SCDM’s Advisory Board, has served on the Board of Trustees and was the 2016 Chair.

  • Patrick Nadolny, Global Head, Clinical Data Management, Sanofi

    Mr. Nadolny has almost 30 years of industry experience across pharmaceutical, device and biologics as well as technology solution development. Mr. Nadolny is a pragmatic leader focusing on technology, innovation, strategic planning, change management, and the setup of new capabilities. Mr. Nadolny is the Global head of Clinical Data Management at Sanofi. In addition to his SCDM board member role, he leads the SCDM innovation committee which recently released 3 reflection papers on the evolution of Clinical Data Management toward Clinical Data Science.

  • Michael Goedde

    Vice President, Global Data Operations, PRA Health Sciences and Chair of the Board at SCDM

June 12, 2020
Fri 5:00 PM CEST

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136